Intimation under Regulation 30 - Rs. 517 Crores Global Sourcing Mandate
Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 18 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 17 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 29 2025
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Announcement Pursuant To Regulation 32 Of SEBI (LODR) Regulations, 2015 - Non Applicability Of Filing Statement Of Deviation / Variation In Utilization Of Funds For Quarter And Year Ended 31St March, 2025
Later from Welcure Drugs and Pharmaceuticals
- Closure of Trading Window
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 27 2025
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 30 2025
- Welcure Wins New? 856 Million Export-Sourcing Orders From Giant Exim & Ravina International - Reg-30 Disclosure
- Completion Of Export-Sourcing Orders Aggregating Rs. 299.91 Crores
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals